Cite
HARVARD Citation
Brand, D. et al. (2019). Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial. Lancet oncology. 20 (11), pp. 1531-1543. [Online].